{"product_id":"abeloffs-clinical-oncology-hardback-9780323476744","title":"Abeloff's Clinical Oncology (Hardback) 9780323476744","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eAbeloff's Clinical Oncology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eEasily accessible, authoritative information for the cancer team\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eJohn E. Niederhuber (Author), James O. Armitage (Author), James H Doroshow (Author), Michael B. Kastan (Author), Joel E. Tepper (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323476744, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 28 March 2019\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e2072 pages, 1352 illustrations (955 in full color)\u003cbr\u003e28.1 x 22.2 x 8.4 cm, 3.92 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eEasily accessible and clinically focused, \u003ci\u003eAbeloff's Clinical Oncology, 6th Edition\u003c\/i\u003e, covers recent advances in our understanding of the pathophysiology of cancer, cellular and molecular causes of cancer initiation and progression, new and emerging therapies, current trials, and much more. Masterfully authored by an international team of leading cancer experts, it offers \u003cb\u003eclear, practical coverage\u003c\/b\u003e of everything from basic science to multidisciplinary collaboration on diagnosis, staging, treatment and follow up.\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eIncludes \u003cb\u003enew chapters\u003c\/b\u003e on Cancer Metabolism and Clinical Trial Designs in Oncology and a standalone chapter on lifestyles and cancer prevention.\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eFeatures \u003cb\u003eextensive updates\u003c\/b\u003e including the latest clinical practice guidelines, decision-making algorithms, and clinical trial implications, as well as new content on precision medicine, genetics, and PET\/CT imaging.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eIncludes \u003cb\u003erevised diagnostic and treatment protocols\u003c\/b\u003e for medical management, surgical considerations, and radiation oncology therapies, stressing a \u003cb\u003emultispecialty, integrated approach\u003c\/b\u003e to care.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eHelps you \u003cb\u003efind information quickly\u003c\/b\u003e with updated indexing related to management recommendations, focused fact summaries, updated key points at the beginning of each chapter \u003cb\u003eideal for quick reference and board review\u003c\/b\u003e, and algorithms for patient evaluation, diagnosis, and treatment options.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eOffers \u003cb\u003emore patient care coverage\u003c\/b\u003e in disease chapters, plus new information on cancer as a chronic illness and cancer survivorship.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eDiscusses \u003cb\u003etoday’s key topics\u003c\/b\u003e such as immuno-oncology, functional imaging, precision medicine, the application of genetics in pathologic diagnosis and sub-categorization of tumors as well as the association of chronic infectious diseases such as HIV and cancer.\u003c\/li\u003e \u003cb\u003e \u003cli\u003eEnhanced eBook version included with purchase. \u003c\/li\u003e\u003c\/b\u003eYour enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eAbeloff’s Clinical Oncology Sixth Edition\u003c\/p\u003e   \u003cp\u003ePART I: SCIENCE AND CLINCIAL ONCOLOGY\u003c\/p\u003e \u003cp\u003eSECTION A: BIOLOGY AND CANCER\u003c\/p\u003e \u003cp\u003e1. Molecular Tools in Cancer Research\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e2. Intracellular Signaling\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e3. The Cellular Microenvironment and Metastases\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e4. Control of the Cell Cycle\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e5. The Pathophysiology of Cancer Cell Death\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e6. Cancer Immunology\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e7. Stem Cells, Cell Differentiation, and Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e8. Vascular and Interstitial Biology of Tumors\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e9. Cancer Metabolism\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION B: GENESIS OF CANCER\u003c\/p\u003e \u003cp\u003e10. Environmental Factors\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e11. DNA Damage Response Pathways and Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e12. Viruses and Human Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e13. Genetic Factors: Hereditary Cancer Predisposition Syndromes\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e14. Genetic and Epigenetic Changes in Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION C: DIAGNOSIS OF CANCER\u003c\/p\u003e \u003cp\u003e15. Pathology, Biomarkers, and Molecular Diagnostics\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e16. Imaging\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION D: CLINICAL TRIALS\u003c\/p\u003e \u003cp\u003e17. Biostatistics and Bioinformatics in Clinical Trials\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e18. Trial Design\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e19. Structures Supporting Cancer Clinical Trials\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e20. Oncology and Health Care Policy\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION E: PREVENTION AND EARLY DETECTION\u003c\/p\u003e \u003cp\u003e21. Discovery and Characterization of Cancer Genetic Susceptibility Alleles\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e22. Lifestyle and Cancer Prevention\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e23. Cancer Screening and Early Detection\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e24. Nicotine Dependence: Current Treatments and Future Directions\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION F: TREATMENT\u003c\/p\u003e \u003cp\u003e25. Cancer Pharmacology\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e26. Therapeutic Targeting of Cancer Cells: Era of Molecularly Targeted Agents\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e27. Basics of Radiation Therapy\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e28. Hematopoietic Stem Cell Transplantation\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e29. Gene Therapy in Oncology\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e30. Therapeutic Antibodies and Immunologic Conjugates\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e31. Complementary and Alternative Medicine\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003ePART II: PROBLEMS COMMON TO CANCER AND THERAPY\u003c\/p\u003e \u003cp\u003eSECTION A: HEMATOLOGIC PROBLEMS AND INFACTIONS\u003c\/p\u003e \u003cp\u003e32. Disorders of Blood Cell Production in Clinical Oncology\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e33. Diagnosis, Treatment, and Prevention of Cancer-Related Venous Thrombosis\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e34. Infection in the Patient with Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION B: SYMPTOM MANAGEMENT\u003c\/p\u003e \u003cp\u003e35. Hypercalcemia\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e36. Tumor Lysis Syndrome\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e37. Cancer-Related Pain\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e38. Cancer Cachexia\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e39. Nausea and Vomiting\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION C: TREATMENT COMPLICATIONS\u003c\/p\u003e \u003cp\u003e40. Oral Complications\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e41. Dermatologic Toxicities of Anticancer Therapy\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e42. Cardiovascular Effects of Cancer Therapy \u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e43. Reproductive Complications\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e44. Paraneoplastic Neurologic Syndromes \u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e45. Neurologic complications\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e46. Endocrine Complications\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e47. Pulmonary Complications of Anticancer Treatment\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION D: POST TREATMENT CONSIDERATIONS\u003c\/p\u003e \u003cp\u003e48. Rehabilitation of Individuals with Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e49. Survivorship\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e50. Second Malignant Neoplasms\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e51. Caring for Patients at the End of Life\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION E: LOCAL EFFECTS OF CANCER AND ITS METASTASIS\u003c\/p\u003e \u003cp\u003e52. Acute Abdomen, Bowel Obstruction, and Fistula\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e53. Superior Vena Cava Syndrome\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e54. Spinal Cord Compression\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e55. Brain Metastases and Neoplastic Meningitis\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e56. Bone Metastases\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e57. Lung Metastases\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e58. Liver Metastases\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e59. Malignancy-Related Effusions\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION F: SPECIAL POPULATIONS\u003c\/p\u003e \u003cp\u003e60. Cancer in the Elderly: Biology, Prevention, and Treatment\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e61. Special Issues in Pregnancy\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e62. Human Immunodeficiency Virus (HIV) Infection and Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003ePART III: SPECIFIC MALIGNANCIES\u003c\/p\u003e \u003cp\u003eSECTION A\u003c\/p\u003e \u003cp\u003e63. Cancer of the Central Nervous System\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION B\u003c\/p\u003e \u003cp\u003e64. Ocular Tumors\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e65. Cancer of the Head and Neck\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION C: SKIN\u003c\/p\u003e \u003cp\u003e66. Melanoma\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e67. Nonmelanoma Skin Cancers: Basal Cell and Squamous Cell Carcinomas\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION D: ENDOCRINE\u003c\/p\u003e \u003cp\u003e68. Cancer of the Endocrine System\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION E: THORACIC\u003c\/p\u003e \u003cp\u003e69. Cancer of the Lung: Non-Small Cell Lung Cancer and Small Cell Lung Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e70. Diseases of the Pleura and Mediastinum \u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e71. Cancer of the Esophagus and Gastroesophageal Junction\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION F: GASTROINTESTINAL\u003c\/p\u003e \u003cp\u003e72. Cancer of the Stomach and Gastroesophageal Junction\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e73. Cancer of the Small Bowel\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e74. Colon Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e75. Cancer of the Rectum\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e76. Cancer of the Anal Canal\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e77. Liver and Bile Duct Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e78. Carcinoma of the Pancreas\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION G: GENITOURINARY\u003c\/p\u003e \u003cp\u003e79. Cancer of the Kidney\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e80. Carcinoma of the Bladder\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e81. Prostate Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e82. Cancer of the Penis\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e83. Testicular Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION H: GYNECOLOGICAL\u003c\/p\u003e \u003cp\u003e84. Cancers of the Cervix, Vulva, and Vagina\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e85. Cancer of the Endometrium\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e86. Ovaries and Fallopian Tubes\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e87. Gestational Trophoblastic Disease\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e88. Cancer of the Breast\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION I: SARCOMAS\u003c\/p\u003e \u003cp\u003e89. Sarcomas of Bone\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e90. Sarcomas of Soft Tissue\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION J\u003c\/p\u003e \u003cp\u003e91. Carcinoma of Unknown Primary\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION K: PEDIATRICS\u003c\/p\u003e \u003cp\u003e92. Pediatric Solid Tumors\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e93. Childhood Leukemia\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e94. Childhood Lymphoma\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION L: HEMATOLOGICAL\u003c\/p\u003e \u003cp\u003e95. Acute Leukemias in Adults \u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e96. Myelodysplastic Syndromes\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e97. Myeloproliferative Disorders\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e98. Chronic Myeloid Leukemia\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e99. Chronic Lymphoid Leukemias\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e100. Hairy Cell Leukemia\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e101. Multiple Myeloma and Related Disorders\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e102. Hodgkin’s Lymphoma\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e103. Non-Hodgkin Lymphoma\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e104. Cutaneous T-Cell Lymphoma and Cutaneous B-Cell Lymphoma\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e105. Adult T-Cell Leukemia-Lymphoma\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46648513200408,"sku":"9780323476744","price":209.59,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323476744_087eb592-8345-4079-adf6-e75aeccbbfe1.jpg?v=1694989834","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/abeloffs-clinical-oncology-hardback-9780323476744","provider":"Freshly Printed Books","version":"1.0","type":"link"}